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Expression of glucose transporters in human peritoneal mesothelial
cells. Glucose containing solutions, the basis of peritoneal dialysis fluids,
affect the proliferation and regeneration of peritoneal mesothelial cells
(MsC). The aim of this study was to examine mechanisms of glucose
transport into MsC, that is, the expression of facilitative glucose trans-
porters (GLUT) and the Na(1)-dependent glucose transporter (SGLT1)
in human primary MsC and a transfected MsC line. Since expression of
both transporters is differentiation dependent, we investigated the effects
of cell differentiation induced by culturing MsC on membranes or by
addition of hexamethylene bisacetamide (HMBA; 6 mM), which enhances
SGLT1 expression in LLC-PK1 cells. Levels of mRNA for GLUT1
through GLUT4 and SGLT1 were evaluated by reverse transcriptase-
polymerase chain reaction (RT-PCR). The presence of the corresponding
proteins was examined by Western blotting and localized by immunoflu-
orescence. Active, Na(1)-dependent glucose transport was assessed by
a-methyl-D-[14C]glucopyranoside (AMG) with and without the SGLT1-
specific inhibitor phlorizin and by patch clamp experiments in NaCl or
choline-chloride. For Na(1)dependent glucose uptake choline chloride
instead of NaCl served as negative control. Facilitative transport was
assessed using 2-fluoro-2-deoxy-[14C]-D-glucose (FDG) with and without
the inhibitors cytochalasin B or phloretin. Primary and transfected MsC
express GLUT1 and GLUT3 mRNA while no transcripts were found for
GLUT2 and GLUT4. No SGLT1 transcript was detectable in subconflu-
ent cells. Semiquantitative RT-PCR analysis documented that the addi-
tion of the differentiation inducer HMBA to confluent cultures or growth
of MsC on membranes for seven days produced a down-regulation of
mRNA for GLUT1, no change for GLUT3, and a substantial increase for
SGLT1 mRNA. Under these conditions MsC express SGLT1 protein and
possess a Na(1)-dependent glucose uptake as assessed by AMG. Phlorizin
(1 mM) inhibits AMG uptake by 30 to 45%. In patch clamp experiments
the addition of extracellular glucose depolarized the membrane potential
only in the presence of sodium. These results indicate that differentiated
MsC express GLUT1, GLUT3, and SGLT1. Further characterization of
these transport mechanisms and their regulation may help to understand
the cellular effects of glucose on MsC in peritoneal dialysis.
Since peritoneal dialysis was introduced as a common thera-
peutic method it has been used as an increasing popular alterna-
tive to hemodialysis. Major drawbacks, however, are frequent
complications such as infections and ultrafiltration failure that
occur as a result of repeated injury to the peritoneal membrane.
A crucial role in maintaining the integrity of the peritoneum is
attributed to peritoneal mesothelial cells (MsC), which have been
studied over the past years with regard to their response to various
toxic stimuli [1]. Maintenance of an osmotic gradient across the
peritoneum is crucial for ultrafiltration. Despite the known toxic
effects of high glucose on MsC [2], it is most commonly used to
generate this osmotic gradient. Model systems of peritoneal
membranes reveal a substantial gradient in glucose concentration
across this membrane. While this gradient is only partially main-
tained by the MsC monolayer the primary route of glucose
absorption is intercellular. Nevertheless, this gradient is signifi-
cantly correlated with mesothelial cell integrety. Furthermore,
mesothelial cell uptake of glucose will influence intracellular
events and may contribute to the pathophysiology of glucose-
induced mesothelial injury. Although the net glucose shift during
peritoneal dialysis has been studied extensively [3], cellular facil-
itative glucose uptake in MsC has only recently been examined
[4]. Mechanisms of active Na(1)/glucose cotransport have not
been studied previously.
To elucidate physiological and pathophysiological effects of
intraperitoneal glucose and investigate the role of glucose trans-
porters as a potential link to MsC injury, knowledge of the
molecular mechanisms of cellular glucose transport is essential.
Glucose transporters in mammalian cells belong to a large family
of membrane proteins that is divided into two classes and types of
genes: the SGLT1 gene encodes for the Na(1)/glucose cotrans-
porter [5], and the GLUT genes for facilitative transporters [6].
Glucose transport in nonepithelial mammalian tissues occurs by
facilitated diffusion mediated by one family of glucose transport-
ers. To date six different transporter isoforms of the facilitative
diffusion type, encoded by distinct genes, denoted GLUT1
through GLUT5 and GLUT7, have been characterized [7]. The
expression of SGLT is restricted to specialized cells of the small
intestine, proximal tubules of the kidney and as recently reported,
to the mesangial cells [8]. The expression of SGLT1 on the apical
surface in addition to GLUT on the basolateral surface of these
cells allows them to perform concentrative uptake from the lumen
as well as transcellular transport of glucose [5]. SGLT1 was also
implicated as one means of water transport across epithelial
membranes [9]. From other cell lines, such as LLC-PK1 cells, it is
known that the expression of SGLT1 and facilitative transporters
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varies with the degree of differentiation [10–12]. Caution is
therefore required when relying on cultured MsC to address
questions that are highly dependent on the presence of differen-
tiated cells.
Based on the common developmental origin along with similar
ultrastructural and functional characteristics of MsC and pneu-
mocytes type II that also possess Na(1)/glucose cotransport, all
potential means of glucose transport in MsC are of interest [13,
14]. We have investigated the expression of each of these facili-
tative transporters, that is, GLUT1 to GLUT4, and Na(1)-
dependent glucose transport, that is, SGLT1. To achieve different
states of cell differentiation, experiments were performed on
regular cell cultures and cells after induction of cell differentia-
tion.
METHODS
Cell culture, characterization and differentiation
Primary MsC were obtained, prepared and cultured as de-
scribed [15]. A transfected human peritoneal mesothelial cell line
(passages number 12-15) had been established in our laboratory
previously [15]. LLC-PK1 and CaCo-2 cells, a cell line derived
from a human colon carcinoma [16], were obtained from ATCC
(Rockville, MD, USA). In brief, primary MsC, transfected MsC,
LLC-PK1 (ATCC no. 101-CL), human fibroblasts and CaCo-2
cells were cultured in DMEM with 10% bovine serum (Serum
supreme; BioWhittaker, Walkersville, CA, USA), penicillin/strep-
tomycin 100 U/100 mg/liter and with additional glucose (final
concentration 2000 mg/liter). In contrast to transfected MsC, the
dishes for primary MsC culture had to be coated with fibronectin
(Sigma, Deisenhofen, Germany). Expression of glucose transport-
ers was induced by chemical differentiation with addition of 6 mM
hexamethylene bisacetamide (HMBA) (Sigma-Aldrich, Stein-
heim, Germany) for seven days or culture on permeable Cyclo-
pore membrane supports for seven days after confluence (Falcon
cell culture insert; pore size 0.45 mm; Stricker, Oberschleibheim,
Germany).
Cell proliferation/toxicity assays
Metyltetrazolium dye test. Proliferation was assessed with a
modified methyl-tetrazolium (MTT) dye procedure [17]. The
MTT-staining (absorbance at 600 nm) for transfected MsC was
found to increase linearly with the cell number from 5 3 103 to
1.2 3 105 cells loaded per well in a 96-well plate (data not shown).
To study the effect of various agents on MsC growth, cells were
seeded with 180 ml medium at a density of 1 3 104 cells per well.
After 14 hours, HMBA was added to the wells at varying
concentrations and incubation continued for two, six and nine
days. All experiments were done in pentaplicate.
Cell count. For counting, the cells were loaded into 24-well
plates at a density of 2 3 104 cells per well. After three days,
HMBA was added to the proliferating cells in different concen-
trations (3 mM; 6 mM). After further incubation for two, six and
nine days cells were trypsinized and the cell count was determined
with a Neubauer chamber and compared to the cell count without
HMBA treatment.
Lactate dehydrogenase release. Transfected MsC were seeded
into 24-well plates, grown to confluency and incubated for two
days or six days with and without HMBA. Medium was collected
and filtered prior to lactate dehydrogenase (LDH) analysis to
remove any detached cells. LDH analysis was performed on an
automatic analyzer (Hitachi 717; Boehringer Mannheim, Germa-
ny).
Reverse transcription and polymerase chain reaction analysis
RNA was extracted from cells grown on 35 mm dishes accord-
ing to the TRIy-Reagent kit protocol [18]. In brief, primary and
transfected MsC were washed once with PBS, then TRIy-Reagent
was added to each well and the lysate frozen in liquid nitrogen.
Chloroform was added to each sample and after incubation for
five minutes on ice, the tubes were centrifuged at 14,000 rpm for
15 minutes. From each tube the upper phase was transferred to a
new DEPC-treated tube. After repetition of the RNA isolation
step for higher purification, the RNA was precipitated by isopro-
panol and centrifugation. RNA was reverse transcribed into
cDNA with oligo(dT) (Boehringer Mannheim) and Super-
ScriptRTy (200 U/ml; Life Technologies, Eggenstein, Germany)
over one hour at 42°C. Sequence-specific oligonucleotide primers
(Table 1) were purchased from Life Technologies. PCR reactions
were performed in a total volume of 25 ml containing: 1 ml of
transcribed cDNA, 103 PCR buffer, 2.5 U AmpliTaqy, (both
Perkin Elmer, Weiterstadt, Germany), 200 mM of each dNTP,
sense and antisense primer (10 pmol), 5 mCi of 32P-dCTP
(Amersham, Braunschweig, Germany). Samples were incubated
for three minutes at 94°C, followed by 30 cycles (35 cycles for
SGLT1) of 45 seconds at 94°C, one minute at 56°C and one
minute at 72°C and a final extension for seven minutes at 72°C in
a Perkin Elmer 9600 Thermal Cycler (Perkin Elmer, Weiterstadt,
Germany). Negative controls consisting of the reaction mixture
without cDNA and not reversely transcribed (RT minus) controls
were included in all reaction series. The cloned cDNAs for the
different glucose transporters served as positive controls. Authen-
ticity of amplified PCR products was verified by specific restriction
site analysis or, for SGLT1, by cycle sequencing on an ABI
PRISM 377 automated sequencer (Perkin Elmer).
Semiquantification of the PCR product. The amplified cDNA
was analyzed on 5% polyacrylamide gel in Tris-borate EDTA
buffer, and visualized with ImageQuant Software on a Storm
Fluorophosphorimager (both Molecular Dynamics, Krefeld, Ger-
many). The intensities of the cDNA bands for the glucose
transporters were normalized to the b-actin band intensities.
Saturation of the PCR product was excluded using serial dilutions.
The stable expression of b-actin mRNA regardless of the state of
cell differentiation was verified with the expression of GAPDH,
another housekeeping gene (data not shown).
Western immunoblotting
Cells were grown in 10 cm dishes and prepared as reported [19].
In brief, cells were washed with PBS once, then solubilized in lysis
buffer (50 mM Tris-HCl, pH 8, 150 mM NaCl, 0.02% sodium azide,
100 mg/ml PMSF, 1 mg/ml aprotinin, 1% Triton X) and harvested.
After centrifugation of the lysate at 12,000 3 g for two minutes at
4°C supernatants were loaded onto Laemmli minigel (7 to 10%).
The separated proteins were transferred to Immobilon mem-
branes (Millipore, Eschborn, Germany) using an electroblotting
system (BioRad, Mu¨nchen, Germany). The filters were blocked
for two hours at room temperature with 5% dry milk and 0.05%
Tween 20 (Flika, Buchs, Switzerland) in Tris-buffered saline and
incubated with antibodies specific for GLUT1 and GLUT3 [19]
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(East Acres, Wak Chemie, Bad Homburg, Germany) at a concen-
tration of 1:800 and 1:500 respectivley. Visualization of bound
antibodies was carried out with the ECL system (Amersham).
Immunofluorescence
Indirect immunoflurescence was performed as previously re-
ported [15]. In brief, cells were grown in chamber slides (Lab-Tek,
Naperville, IL, USA) until complete confluency was reached, fixed
in 1:1 (vol:vol) methanol/acetone, washed with PBS and TWEEN
(Flika) and then incubated with the antibodies against GLUT1,
GLUT3 and SGLT1 (diluted 1:40, Wak Chemie) or hyperimmune
serum. After 60 minutes unbound antibodies were washed off and
the cells were incubated for another 60 minutes with 50 ml of a
FITC- (for GLUT1 and SGLT1) or TRITC-conjugated secondary
antibody (diluted 1:40 in PBS; Sigma). Specific staining was
compared with negative controls that were processed with hyper-
immune serum in the absence of the respective primary antibody.
Immunofluorescence micrographs were obtained using a micro-
scope (Leica DMRBE, Germany) equipped for photography
(Leica DMRD, Germany) with Kodak films.
Hexose uptake determinations
Methyl(alpha-D-[U-14C]gluco)pyranoside (AMG) uptake. Mea-
surements were performed as previously reported [8]. Cells were
washed with 2 ml of 20 mM Tris/HEPES buffer, pH 7.4, containing
1 mmol/liter CaCl2, 5 mmol/liter KCl, 2,5 mmol/liter MgSO4 and
either 150 mmol/liter NaCl or 150 mmol/liter choline cloride and
preincubated in 2 ml of these NaCl or choline chloride solutions
for 20 minutes with or without 0.5 mM phlorizin (Sigma). For the
glucose uptake experiments, the appropriate solutions were re-
newed and AMG (Amersham, Buckinghamshire, UK) was added,
resulting in final radioactive concentrations ranging from 0.1 to
1.0 mCi (0.3 to 3 mmol/liter) in an incubation volume of 1 ml per
well. After incubation at 37°C for 60 minutes, cells were washed
three times with 2 ml of ice-cold PBS, containing 0.5 mM phlorizin.
The cells were then solubilized with 1.5 ml 0.1 M NaOH 1 1%
SDS per dish at room temperature for two hours. 400 ml were
added to 3 ml of Quickszint 2000 (Zinsser Analytic, Maidenhead,
UK) and radioactivity determined with a beta liquid scintillation
counter (Wallac Oy, Turku, Finland) employing the ESR-meth-
ode for 14C counting. The remaining cell lysate was used for
protein measurement. For experiments with cells on filter mem-
branes DMEM/AMG with or without phlorizin was added to the
apical side of the cells for incubation but otherwise processed
identically [20, 21].
2-Fluoro-2-deoxy-[14C]-D-glucose (FDG) uptake. Cells were
washed and pre-incubated for 20 minutes in 2 ml PBS each. For
uptake determination, radiolabeled FDG (Amersham) with or
without the uptake-inhibitors cytochalasin B (10 mmol/liter) or
phloretin (0.2 mmol/liter; both Sigma) [22] was added to 1 ml of
this medium resulting in final concentrations of 0.33 to 1.0 mCi (1
to 3 mmol/liter). After incubation at 37°C for 30 minutes, cells
were washed three times with 2 ml of ice-cold PBS, containing
cytochalasin B or phloretin. The cells were then solubilized and
processed as in AMG uptake studies.
Na(1)/glucose currents in mesothelial cells
To determine Na1/glucose cotransport-dependent depolariza-
tion of membrane potential, transfected MsC were grown on
coated glass coverslips and mounted in a superfusion chamber.
Standard patch clamp techniques, in the whole-cell, current clamp
mode, were applied to the apical surface of postconfluent coble
stone-shaped cells. Experiments were performed at room temper-
ature using an Axopatch 200A amplifier (Axon Instruments, Inc.,
Foster City, CA, USA), a Zeiss IM-35 inverted microscope with
DIC optics (Zeiss, Oberkochen, Germany), and a Narishige
WR-88 hydraulic micromanipulator (Narishige Scientific Instru-
ment Laboratory, Tokyo, Japan). Recording pipettes (2 Mohm, 2
mm inner tip diameter; whole cell input and series resistance
usually 0.5 to 1 Gohm and 20 Mohm, respectively) were manu-
factured from 1.5 mm borosilicate glass (GC 150 TF-10; Clark
Medical Instruments, Pangbourne, UK) by a microprocessor-
driven two-stage electrode puller (Zeitz Instruments, Augsburg,
Germany). The pipette solution was (mM): 100 K-D-gluconate, 33
KCl, 3 EGTA (ethylene glycol-bis (b-aminoethyl ether)-
N,N,N9,N9 -tetraacetic acid), 1.82 MgCl2 (0.8 free Mg
21), 1
Table 1. Oligonucleotide primer pairs used for RT-PCR
Gene Oligonucleotide primers 59–39
Nucleotides
no.
Product
size
Gene
bank no.
SGLT1 S TCTTCGATTACATCCAGTCCA 1365–1385 521 M24847
AS TCTCCTCTTCCTCAGTCATC 1867–1886
GLUT1 S TCCACGAGCATCTTCGAGA 1059–1077 392 K03195
AS ATACTGGAAGCACATGCCC 1433–1451
GLUT2 S CACTGATGCTGCATGTGGC 958–976 521 J03810
AS ATGTGAACAGGGTAAAGGCC 1460–1479
GLUT3 S TTCAAGAGCCCATCTATGCC 1144–1163 457 M20681
AS GGTCTCAGGGACTTTGAAGA 1582–1601
GLUT4 S GGCATGTGTGGCTGTGCCATC 1220–1240 413 M20747
AS GGGTTTCACCTCCTGCTCTAA 1613–1633
b-actin S AACCGCGAGAAGATGACCCAGATCATCTTT 385–413 350 X00351
AS AGCAGCCGTGGCCATCTCTTGCTCGAAGTC 705–734
GAPDH S CCCATCACCATCTTCCAGGAGC 218–239 473 J02642
AS CCAGTGAGCTTCCCGTTCAGC 670–690
Abbreviations are: Sense (S) and antisense (AS) primer pairs specific for sodium/glucose transporter (SGLT1), facilitative glucose transporter
isoforms (GLUT1-4), b-actin, and glycerophosphate dehydrogenase (GAPDH). Nucleotide numbers refer to positions within the published sequence.
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K2ATP, 0.171 CaCl2 (10
28 M free Ca21) and 10 mM HEPES
(N-2-hydroxyethylpiperazine-N9-2-ethanesulfonic acid, titrated to
pH 7.2 with KOH). Monolayers were continously superfused
using NaCl and choline chloride solutions as used for AMG-
uptake studies in the presence or absence of 10 mM glucose.
Recorded membrane potentials were stored on a DAT tape
(DTR-1204 DAT Recorder; Bio-Logic Co., Claix, France), and
analyzed graphically after plotting.
Statistical analyses
Hexose uptake studies. All data are presented as the mean 6
SEM. The Mann-Whitney U-test (two-tailed) was used for statis-
tical determinations and P , 0.05 was considered significant.
Na(1)/glucose currents, MTT test and cell counts in MsC.
Differences between mean values were estimated by t-test or
Welsh’s approximation (two-tailed) using InStat (GraphPad Soft-
ware, Inc., San Diego, CA, USA). P values of P , 0.05 were
considered significant.
RESULTS
Cell proliferation/toxicity assay
After incubation with HMBA, MsC showed a dose dependent
reduction of cell proliferation as assessed by the MTT assay (Fig.
1A) and cell count (Fig. 1B). Simultaneous determinations of
LDH release failed to show any change (Fig. 1C).
Identification of mRNAs for the glucose transporters
Primary as well as transfected MsC expressed GLUT1 and
GLUT3 in every state of differentiation (Fig. 2). RT-PCR de-
tected no specific amplification product for GLUT2 and GLUT4
transcripts. Further semiquantitative RT-PCR analysis docu-
mented differentiation dependent changes for GLUT1 and
SGLT1, but not for GLUT3. The addition of HMBA to confluent
cultures or the growth on filters produced a down-regulation of
GLUT1 mRNA and a substantial increase in SGLT1 mRNA,
whereas the latter transcript was not detectable in subconfluent
cells (Fig. 2). After sequencing, the amplified 521 bp PCR-product
of the intron-spanning SGLT1 oligonucleotide primer pairs pre-
sented 100% identity with the 1365-1886 nucleotide of human
SGLT1 [23]. In confluent cells the expression of GLUT1 as well as
SGLT1 mRNA varied considerably, probably due to asynchro-
nous differentiation, ranging from levels seen in subconfluent cells
to those seen in HMBA-treated cultures (not shown). Negative
controls for the RT-PCR consisted of the reaction mixture
without cDNA, not reversely transcribed (RT minus) controls and
of fibroblasts. The cloned cDNAs for the different glucose
transporters as well as the cDNA of CaCo-2 cells, a human colon
™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™3
Fig. 1. Effect of hexamethylene bisacetamide (HMBA) on the prolifera-
tion rate of mesothelial cells (MsC) assessed by the methyltetrazolium
(MTT) test (A) and cell counting (B). Medium was supplemented with the
concentrations of HMBA as indicated. Each MTT-test bar represents the
mean of five different experiments. Symbols are: (u) 0 mM; (f) 3 mM; (M)
6 mM. Cell counting experiments were done in pentaplicate and results are
mean 6 SD. *P , 0.05 compared to control without HMBA pretreatment.
(C) Effect of HMBA on the release of LDH from MsC into the medium.
Medium was supplemented with the concentrations of HMBA as indi-
cated and LDH was measured at indicated time points after initiation of
treatment. Each bar represents the mean 6 SD of 4 wells.
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carcinoma cell line known to express GLUT1, GLUT3 and
SGLT1 [16, 24], yielded positive results.
Western blotting
Using a specific antibody directed against GLUT1, a character-
istic band of 46 kDa could be observed on Western blotting. A 46
kDa band of GLUT3 was detected only in human CaCo-2 cells,
which served as a positive control for GLUT3 protein, but not in
MsC (Fig. 3) [20].
Immunofluorescence
As shown in the immunofluorescence micrographs diffuse
positive staining sparing the nucleus is noticed for GLUT1 in
transfected as well as primary MsC (Fig. 4A). In transfected MsC
staining for SGLT1 was positive (Fig. 4B). Fluorescence for
GLUT3 was only slightly above background in MsC and CaCo-2
cells (Fig. 4 D, E).
Demonstration of Na(1)-dependent a-methyl-D-
[14C]glucopyranoside-glucose uptake
a-Methyl-D-[14C]glucopyranoside (AMG) is a non-metaboliz-
able glucose analog specific for the Na(1)-dependent glucose
Fig. 2. Levels of messenger RNA for SGLT1,
GLUT1, GLUT3 and b-actin in mesothelial
cells (MsC) in different differentiation states as
evaluated by RT-PCR. (A) Subconfluent state,
after hexamethylene bisacetamide (HMBA)
pretreatment for seven days and after growth
on filter for seven days. (B) Relative signal
intensities are shown graphically for SGLT1
and GLUT1, GLUT3 for three different sets of
experiments and are presented as mean 6 SEM.
The intensities of the cDNA bands for each
protein were normalized to the b-actin band
intensities.
Fig. 3. Western immunoblotting of transfected mesothelial cells (MsC)
using antibodies against GLUT1 (A) and GLUT3 (B). Electroblotting of a
protein preparation from transfected MsC, primary cultures and CaCo-2
cells (positive control) was performed. Incubation with the respective
antibodies shows a characteristic band at 46 kDa, representative of the
transporter.
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transport [25]. Phlorizin is a competitive, non-transported inhib-
itor of SGLT1 [5]. In HMBA treated MsC, and in MsC grown on
filters, we measured a 30 to 45% reduction of AMG uptake after
addition of phlorizin. This indicated the presence of SGLT in
differentiated MsC (Fig. 6A). In HMBA-pretreated fibroblasts
(SGLT1 mRNA negative) and in subconfluent, proliferating MsC,
there was no phlorizin-sensitive AMG uptake. Compared to
differentiated MsC, AMG uptake in HMBA-treated CaCo-2 cells
was four- to sevenfold higher with an uptake inhibition of about
77% by phlorizin. HMBA-treated LLC-PK1 cells yielded an
approximately 100- to 150-fold increased intracellular activity of
AMG that could be blocked by more than 99% by phlorizin (Fig.
Fig. 4. Indirect immunofluoresence staining of transfected mesothelial cells (MsC) for GLUT1 (A), SGLT1 (B), negative control FITC (C), GLUT3
in MsC (D), negative control TRITC (E), and a positive control for GLUT3 (CaCo-2 cells, F). Cells were incubated with a primary antibody against
GLUT1, GLUT3 or SGLT1 followed by staining with FITC- or TRITC-conjugated secondary antibodies as described in the Methods section. At a
magnification of 3200 diffuse staining with sparing of the nuclei is noted.
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6A). The nonphlorizin-inhibitable fraction of AMG uptake aver-
aged 3.9 pmol/mg protein/hr and was similar in all cell types
tested. When replacing Na(1) by choline chloride, no effect of
phlorizin on AMG uptake could be observed (Fig. 5). These
results are consistent with a Na(1)-dependent phlorizin-inhibit-
able component of glucose uptake by MsC.
Na(1)/glucose currents
Initial membrane potentials recorded in a NaCl bath solution
were low (215 6 1 mV, N 5 6). Addition of 10 mM D-glucose
depolarized and subsequent removal of glucose repolarized the
membrane potential to 27 6 2 mV and 212 6 2 mV, respec-
tively, within several minutes of incubation (Fig. 7). The addition
of glucose into a medium where NaCl was replaced by choline
chloride slowly hyperpolarized membrane potentials (from
214.7 6 2.5 mV to 222.7 6 2.1 mV to 225.5 6 4.1 mV, not
shown), again supporting the presumed presence of a Na(1)-
dependent glucose transporter.
Demonstration of facilitative transport
2-Fluoro-2-deoxy-[14C]-D-glucose (FDG) uptake is mediated
only by the facilitative transporter isoform (GLUT) and can be
blocked by cytochalasin B and phloretin [22]. The uptake of FDG
increased linearly both with time over a period of 60 minutes and
with increasing concentrations of FDG added (data not shown).
In FDG transport studies with similar absolute and specific
activity as in AMG studies, 50- to 150-fold higher counts of beta
activity were obtained and could be blocked by 90% by cytocha-
lasin B (10 mM; data not shown) and by 99% by phloretin (0.2
mM). The differentiation dependence of the facilitative glucose
transport was demonstrated analyzing the FDG uptake of sub-
confluent, confluent and HMBA-treated MsC (N 5 3 per group).
The sugar uptake of subconfluent cells was not different from
confluent MsC but was 55% higher than the uptake of HMBA-
treated cells (Fig. 6B). These findings indicate a differentiation
dependent facilitative glucose transport in MsC with down-
regulation of glucose uptake in differentiated cultures.
DISCUSSION
This study was directed toward at a better understanding of the
cellular mechanisms of glucose transport into MsC and the effects
of cell differentiation thereon. We demonstrated for the first time
that both facilitated and Na(1)-dependent glucose transporters
are present in human peritoneal MsC.
Differentiation can be induced either through the culture of
MsC cells on membranes which causes polarization, or through
the addition of the chemical differention inducer HMBA to
confluent cultures [26]. HMBA initiates relatively synchronous
differentiation compared to the slow asynchronous differentiation
observed spontaneously following cell confluence [27]. We found
other evidence of cell differentiation such as reduced prolifera-
tion. The addition of HMBA, not toxic below 10 mM [28] in other
cell types, resulted in stable cell counts without an increase in
LDH release in our model, thus strongly supporting the assump-
tion of reduced cell proliferation without cell damage.
Growing cells and terminally differentiated cells were found to
have very different profiles of glucose metabolism and uptake.
Na(1)-dependent glucose transport activity was not detected in
dividing or in subconfluent cultures of LLC-PK1 cells [26, 28]. In
LLC-PK1 cells the Na(1)/glucose cotransport activity serves as a
marker of differentiation [11] that can be achieved with HMBA,
one of the most potent differentiation inducers identified to date
[12, 29]. The addition of HMBA to confluent LLC-PK1 cultures
produces a substantial increase in Na(1)/glucose cotransport
activity [12, 28]. Our studies demonstrated regular SGLT1 mRNA
expression and transport activity only in confluent primary MsC
and transfected MsC after the addition of HMBA or when grown
on membranes. These observations indicate that the growth of
monolayers on a permeable support mimics the effects of HMBA
on monolayers grown on plastic. Further evidence for Na(1)-
dependent glucose uptake is provided by the AMG uptake studies
where the addition of phlorizin, a SGLT1 specific inhibitor,
reduced glucose uptake by 30 to 45%. Compared with undiffer-
entiated MsC where no SGLT1 mRNA and no significant phlo-
rizin-sensitive AMG uptake was observed, this strongly supports
the hypothesis of a differentiation dependent expression of
SGLT1 in human peritoneal MsC, which is also consistent with
the results observed in primary MsC. However, in our experi-
ments the SGLT1 activity in MsC represents only about 20% of
that in CaCo-2 cells and 1% of that in LLC-PK1 cells, both cell
types designed for Na(1)-dependent glucose uptake [30].
The identification of SGLT1 in MsC suggests the possibility of
transcellular glucose transport similar to that seen in specialized
Fig. 5. Effect of phlorizin on methyl(a-D-[U-14C]gluco)pyranoside
(AMG) uptake by mesothelial cells (MsC) in the presence and absence of
Na(1) ions. After growing on filters for seven days, the cells were
incubated for 60 minutes with AMG (1.5 mmol/liter, 0.5 mCi/ml) in the
presence of 150 mmol/liter NaCl or 150 mmol/liter choline chloride with
(1) or without (2) phlorizin (0.5 mmol/liter) as described in the Methods
section. Determinations of AMG uptake are expressed as pmols per mg
cell protein per hour (mean 6 SEM, N 5 3).
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epithelia such as the intestine and renal tubules [5, 31], and
appears to be of special interest in the light of a recently proposed
participation of SGLT1 in transepithelial water transport [9].
Furthermore, SGLT1 may contribute to glucose uptake of MsC
during peritoneal dialysis and the resulting cellular events.
The investigation of facilitative glucose transport in MsC in our
studies with RT-PCR, Western blotting, immunofluorescence and
FDG uptake identified GLUT1 on messenger RNA and protein
level and GLUT3 on mRNA level only. This divergence may be
due to the increased sensitivity of RT-PCR compared to Western
blotting or immunofluorescence. The occurrence of artifacts in
the RT-PCR analyses was ruled out using CaCo-2 cells as positive
and fibroblasts as negative controls for the different glucose
transporters. The facilitative glucose transport in MsC shows a
down-regulation both in expression of GLUT1 mRNA and in
FDG uptake with increasing differentiation. Although SGLT1 is
up-regulated in the differentiated state, the uptake studies with
radiolabeled glucose analogs show that FDG transport exceeds
AMG transport despite the equimolar concentrations used and
specific activities that did not differ. The relatively low expression
of SGLT1 activity compared with other epithelia such as CaCo-2
cells or LLC-PK1 cells suggests that the facilitative transporters
are probably the major route of glucose uptake into MsC. In this
setting the relative role of transcellular compared with intercellu-
lar glucose transport in vivo has to be considered. Therefore, the
extent to which such a distinct glucose transport system influences
net transport characteristics remains unclear. However, even
under the assumption of exclusively intercellular glucose trans-
port, the expression of these transporters will determine MsC
uptake and may be important as a pathophysiologic link between
peritoneal glucose exposure and MsC injury.
Our findings also suggest that transfected MsC can be present
in various states of differentiation. Therefore, we consider trans-
fected MsC an adequate model for the study of cellular glucose
transport and dialysate toxicity, especially if a differentiated
phenotype is induced through culture on membranes or pretreat-
ment with HMBA.
The glucose transporters present in MsC, including SGLT1,
GLUT1 and GLUT3, have relatively high affinities for glucose [5],
implicating that their activity is near maximum at physiologic
levels of intraperitoneal/extracellular glucose concentration. This
suggests that factors or conditions that affect the expression of
Fig. 6. (A) Phlorizin-dependent inhibition of
methyl(a-D-[U-14C]gluco)pyranoside (AMG)
uptake. LLC-PK1 cells (positive control),
hexamethylene bisacetamide (HMBA)-
pretreated fibroblasts (negative control),
transfected mesothelial cells (MsC) in various
states of differentiation and primary MsC were
incubated with AMG with or without the
addition of phlorizin. For the graphical
presentation, data of independent experiments
were normalized by means of the respective
controls without phlorizin. Numbers above the
bars indicate the number of experiments
performed. Data are presented as mean 6 SEM.
*P , 0.05 and **P , 0.01 compared to control
without phlorizin. (B) Differentiation
dependent uptake of 2-fluoro-2-deoxy-[14C]-D-
glucose(FDG). Effect of differentiation on the
facilitative glucose transport in MsC. Confluent
cells grew in culture for 12 days before
incubation; half of them were treated with 6
mM HMBA for six days. Subconfluent cells
were used five days after seeding and all cells
were incubated with FDG (1.0 mmol/liter, 0.33
mCi). Phloretin (0.2 mM) was used as specific
inhibitor of facilitative glucose transport in
subconfluent cultures.
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glucose transporters on MsC could alter intracellular glucose
concentration and thus affect cell function. Changes in the
expression of glucose transporters in MsC may influence MsC
biology and thus a number of physiological and pathophysiologi-
cal processes, such as the response to intraperitoneal inflamma-
tion, regulation of matrix protein production or peritoneal fibrosis
during peritoneal dialysis.
Conclusion
The identification of distinct transport systems in MsC is
essential for understanding the mechanism of cellular uptake and
transperitoneal glucose transport during CAPD. The present
study indicates that glucose uptake by MsC is mediated by both
SGLT1 and the facilitative glucose transporters. The identifica-
tion of SGLT1 in differentiated MsC is not unexpected in view of
their polar and epithelial nature. Further studies of the expression
and possible regulation of the SGLT1 appear warranted in light of
the potential role for water transport across epithelia and the
cellular pathophysiology of glucose.
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APPENDIX
Abbreviations used in this article are: AMG, a-methyl-D-[14C]glucopy-
ranoside; CaCo-2, cell line derived from human colon carcinoma; EGTA,
ethylene glycol-bis (b-aminoethyl ether)-N,N,N9,N9-tetraacetic acid; FDG,
2-fluoro-2-deoxy-[14C]-D-glucose; GLUT, facilitative glucose transport-
ers; HEPES, N-2-hydroxyethylpiperazine-N9-2-ethanesulfonic acid;
HMBA, hexamethylene bisacetamide; MsC, mesothelial cells; MTT,
methyltetrazolium; RT-PCR, reverse transcription-polymerase chain re-
action; SGLT1, Na(1)-dependent glucose transporter.
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